Next Article in Journal
The Impact of Serotype Cross-Protection on Vaccine Trials: DENVax as a Case Study
Next Article in Special Issue
COVID-19 Infection Detection and Prevention by SARS-CoV-2 Active Antigens: A Synthetic Vaccine Approach
Previous Article in Journal
Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines
Previous Article in Special Issue
COVID-19 Vaccines Currently under Preclinical and Clinical Studies, and Associated Antiviral Immune Response
 
 
Communication

Article Versions Notes

Vaccines 2020, 8(4), 673; https://doi.org/10.3390/vaccines8040673
Action Date Notes Link
article pdf uploaded. 12 November 2020 13:01 CET Version of Record https://www.mdpi.com/2076-393X/8/4/673/pdf-vor
article supplementary file uploaded. 12 November 2020 13:01 CET - https://www.mdpi.com/2076-393X/8/4/673#supplementary
article xml file uploaded 13 November 2020 04:56 CET Original file -
article xml uploaded. 13 November 2020 04:56 CET Update -
article pdf uploaded. 13 November 2020 04:56 CET Updated version of record https://www.mdpi.com/2076-393X/8/4/673/pdf-vor
article html file updated 13 November 2020 04:57 CET Original file -
article xml file uploaded 30 November 2020 03:25 CET Update -
article xml uploaded. 30 November 2020 03:26 CET Update https://www.mdpi.com/2076-393X/8/4/673/xml
article pdf uploaded. 30 November 2020 03:26 CET Updated version of record https://www.mdpi.com/2076-393X/8/4/673/pdf
article html file updated 30 November 2020 03:49 CET Update -
article html file updated 23 July 2022 00:48 CEST Update https://www.mdpi.com/2076-393X/8/4/673/html
Back to TopTop